Health Canada has amended the Special Access Programme (SAP), allowing physicians to request patient access to restricted drugs and psychedelic treatments like psilocybin- and MDMA-assisted therapy.
Story continues below
This advertisement has not loaded yet, but your article continues below.
The amendments went into effect earlier this week, after being published in the Canada Gazette , the official newspaper of the Government of Canada.
The changes mean doctors will be able to request access for patients with treatment-resistant or life-threatening conditions, and each request will be assessed on a case-by-case basis.
Previously, Canadians were accessing psilocybin-assisted psychotherapy through clinical trials or Section 56 exemptions to the Controlled Drugs and Substances Act. Obtaining an exemption, however, which is granted
Read full article on The Growth Op
